PARP1/7 dual inhibitor therapy(Duke Street Bio)

N/A

Report date: 2024/07/12 15:24:39

Base Information

Drug NamePARP1/7 dual inhibitor therapy(Duke Street Bio)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitorsTCDD-inducible poly [ADP-ribose] polymerase inhibitors

TargetsPoly (ADP-Ribose) polymerase 1TCDD-inducible poly [ADP-ribose] polymerase

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDuke Street Bio Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A